HRT and weight-loss drugs: what does the new study actually tell us?

When a headline feels personal

You've been trying to understand why your body feels different. Then a headline suggests that women using hormone therapy lost more weight on a weight-loss medicine. It's easy to wonder whether you've been missing an important part of the picture.

Maybe you're already taking one treatment. Maybe you're considering both. Or perhaps you're simply tired of being told that the answer is to try harder.

Before turning a research finding into a shopping list for your next appointment, take a closer look at what was compared. A promising result can raise a useful question without settling what you should do.

What the researchers compared

In January 2026, Mayo Clinic reported a study of tirzepatide and menopause hormone therapy. It included 120 postmenopausal women with overweight or obesity who had used tirzepatide for at least 12 months. Women using hormone therapy had greater weight loss than women who weren't using it.

This was an observational study. Researchers compared existing treatment experiences, rather than randomly assigning women to receive hormones or no hormones. That distinction matters because the groups could differ in ways that also affect their results.

The study's publication record identifies it as a retrospective cohort study. The finding is a reason to investigate further, not proof that adding hormones caused the difference.

What does “35 percent more” mean?

Mayo's report describes about 35 percent greater weight loss in the hormone-therapy group. That does not mean the women lost 35 percent of their starting body weight.

Here's a made-up example to explain the arithmetic. If one group lost 10 units and another lost 13.5, the second lost 35 percent more than the first. Those are illustrative numbers, not the results of this study.

When you read a percentage, ask, “A percentage of what?” Is the article describing starting weight, a difference between groups, or the chance of an outcome? Those can sound similar in a headline while describing very different things.

What the study cannot settle for you

The researchers acknowledge that other differences, including health behaviors and possible improvements in sleep or symptoms, could help explain the association. More research is needed to separate those possibilities.

It also doesn't tell you that your experience would match the average. You have your own medical history, reasons for considering treatment and priorities. You may care more about feeling comfortable moving, improving a health measure or sleeping through the night than about reaching a particular number.

If your concern is specifically a changing waistline during menopause, name that. It isn't necessarily the same concern as deciding whether a prescription weight-management treatment is appropriate.

Two treatments need two clear reasons

A useful appointment question is, “What would each treatment be for in my situation?”

If you're struggling with hot flashes, discuss those symptoms on their own terms. Our article on new menopause treatment guidance explains that conversation. If you're considering a weight-loss medicine, ask separately about eligibility, expected benefits, side effects, costs and follow-up.

Don't let the possibility of a combined effect replace either discussion. You should be able to explain why each medicine is being considered without relying on the other one to justify it.

You might say, “I saw this study and wondered whether it applies to me. What does it change, if anything, about the options we were already discussing?” That invites an answer grounded in your circumstances.

Bring the full picture, including what feels difficult

What has changed recently? Are you sleeping differently? Has movement become harder to fit around work or caring responsibilities? Are symptoms affecting your appetite or your willingness to go out?

These questions help describe your life. They aren't a way to assign blame or diagnose yourself. If night waking is part of the story, mention what happens and how often. Bring a list of medicines and supplements, plus any treatments you've tried and why you stopped.

Ask what happens after the first prescription too. How will progress be assessed? What should prompt a call? What happens if the cost becomes difficult or the treatment doesn't help as expected? A plan needs to work beyond the first few weeks.

If you're already using one of these medicines, bring the timeline. When did you start, what changed afterwards, and what still bothers you? You don't need a perfect chart. A few examples can help keep the discussion focused on your experience instead of an average from a group of other women.

Make room for goals beyond the scale

Try writing down two changes you'd like to notice in everyday life. Perhaps you'd like walking to feel easier, meals to feel less stressful, or symptoms to interrupt your work less often.

You can want medical help and also want a kinder relationship with your body. Our discussion of body confidence after forty makes space for both.

You don't have to dismiss this research or rush to act on it. Bring the question, ask what the evidence can support, and leave with a plan that makes sense for you.

Sources & further reading

• Mayo Clinic reported a study of tirzepatide and menopause hormone therapy ↗
• study's publication record ↗

Read our editorial standards.